Insights on the Liposomal Doxorubicin Global Market to 2026 - by Product, Application and Region
December 06, 2021 06:08 ET
|
Research and Markets
Dublin, Dec. 06, 2021 (GLOBE NEWSWIRE) -- The "Liposomal Doxorubicin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
China Nivolumab Market Market Report 2021: Sales Value Increased from CNY9.9 Million in 2018 to CNY 43.1 Million in 2020 - Forecast to 2025
June 02, 2021 04:33 ET
|
Research and Markets
Dublin, June 02, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Nivolumab Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. According to this market...
Global Liver Cancer Hepatoma Markets, Epidemiology and Patient Flow Report 2020-2035
May 17, 2021 06:43 ET
|
Research and Markets
Dublin, May 17, 2021 (GLOBE NEWSWIRE) -- The "Global Liver Cancer Hepatoma Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering. Global Liver Cancer...
Advanced Liver Cancer Drug Pipeline Prospers with an Inrush of Pharma Companies and Emerging Novel Therapies
April 29, 2021 20:30 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, April 29, 2021 (GLOBE NEWSWIRE) -- Advanced Liver Cancer Drug Pipeline Prospers with an Inrush of Pharma Companies and Emerging Novel Therapies A comprehensive analysis of...
Global Hepatocellular Carcinoma Market Analysis 2019-2020 & 2029 - High Level of Unmet Needs Leaves Room for Further Research & Opportunity for Pipeline Agents with First-in-Class Approvals
April 15, 2021 05:13 ET
|
Research and Markets
Dublin, April 15, 2021 (GLOBE NEWSWIRE) -- The "Hepatocellular Carcinoma - Opportunity Analysis and Forecasts to 2029" report has been added to ResearchAndMarkets.com's offering. The pipeline drugs...
Global Hepatocellular Carcinoma Treatment Market 2021-2025: Market Sizing, Market Forecast and Key Vendor Profiles
March 08, 2021 07:33 ET
|
Research and Markets
Dublin, March 08, 2021 (GLOBE NEWSWIRE) -- The "Global Hepatocellular Carcinoma Treatment Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. The hepatocellular carcinoma...
Global Liver Cancer Therapeutics Markets Report 2020: Historical Data 2015-2018, Base Year of 2019, Estimates for 2020 & Forecasts 2021-2025
January 19, 2021 07:33 ET
|
Research and Markets
Dublin, Jan. 19, 2021 (GLOBE NEWSWIRE) -- The "Global Liver Cancer Therapeutics Market, by Cancer Type, by Therapy, by Equipment, by Age, by Factors, by Route of Administration, by Distribution...
Hepatocellular Carcinoma Epidemiology Forecast Report 2020: Diagnosed Incident Cases and Five-year Diagnosed Prevalent Cases for 2019-2029
January 12, 2021 09:43 ET
|
Research and Markets
Dublin, Jan. 12, 2021 (GLOBE NEWSWIRE) -- The "Hepatocellular Carcinoma - Epidemiology Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. The Hepatocellular Carcinoma...
North America Liver Disease Treatment Market to Hit $8.31 Billion by 2027: AMR
October 26, 2020 09:56 ET
|
Allied Market Research
Portland, Oct. 26, 2020 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the North America Liver Disease Treatment Market accounted for $6.97 billion in 2019, and is...
Liver Cancer Hepatoma Clinical Trials Pipeline 2020 and Products Forecast to 2025
September 07, 2020 07:18 ET
|
Research and Markets
Dublin, Sept. 07, 2020 (GLOBE NEWSWIRE) -- The "Global Liver Cancer Hepatoma Clinical Trial Pipeline Highlights - 2020" report has been added to ResearchAndMarkets.com's offering. The report...